Alcon to acquire LumiThera to enhance dry AMD treatment
The acquisition includes LumiThera’s photo-bio-modulation (PBM) device, which leverages low-level light to treat early and intermediate dry age-related macular degeneration (AMD).
Morphic Medical receives CE mark for RESET system to treat obesity and diabetes
SoundHealth unveils Android app for AI-powered SONU Band
C-RAD expands US market presence with new service agreement
China bars European medical device firms from government contracts
Kuon Healthcare expands UK diagnostic services with enhanced accessibility
Analysis
View MoreBreaking data silos in the cloud
How long and complex healthcare supply chains perform depends on how effectively data is shared at all stages. Yet that data is often locked in silos, guarded by closed systems...
More Analysis
White Papers
View More
Simulating sustainability
Spinal cord regeneration
The pros of zwitterionic polymers
Better biosensing with nanomaterials